Form 4: INSMED Director Leo Lee Sells 75,000 Shares
Insider Transaction Report
INSMED Inc. Director Leo Lee executed sales of 75,000 shares of common stock on November 17, 2025, under a Rule 10b5-1 plan.
Summary
- Leo Lee, a Director of INSMED Inc. (INSM), sold a total of 75,000 shares of common stock on November 17, 2025.
- The sales were executed in multiple transactions at weighted average prices ranging from $193.51 to $197.40 per share.
- These transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged sale plan.
- Following these transactions, Leo Lee's direct beneficial ownership of INSMED common stock stands at 54,677 shares.
Sentiment
Score: 5
Explanation: The filing reports a routine insider sale under a pre-arranged 10b5-1 plan, which typically has a neutral sentiment as it's not necessarily indicative of a change in the insider's view of the company's prospects.
Future Outlook
NA
Industry Context
Insider transactions, particularly sales by directors, are routinely monitored by investors as they can sometimes signal management's perception of the company's future prospects or simply be for personal financial planning. Sales executed under a Rule 10b5-1 plan are pre-scheduled and generally considered less indicative of immediate sentiment compared to open-market, unscheduled sales.
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Power of Attorney Delegation | Leo Lee granted a Limited Power of Attorney to Michael A. Smith, Katrina S. Atieh, and Ian S. Macdonald to prepare, execute, and file SEC Forms 3, 4, 5, and 144 on his behalf. This includes obtaining EDGAR credentials and acting as an account administrator. | 2025-08-06 | Streamlines the process for SEC compliance filings for the director, ensuring timely and accurate reporting of beneficial ownership changes. |
Stakeholder Impact
- Shareholders: May observe the director's stock sales, which could be interpreted in various ways, though the 10b5-1 plan suggests a pre-planned financial move rather than a reaction to new information.
Key Dates
| Date | Description |
|---|---|
| 2025-08-06 | Date of execution for the Limited Power of Attorney by Leo Lee. |
| 2025-11-17 | Date of earliest transaction reported for the sale of common stock. |
| 2025-11-18 | Date the Form 4 was signed by Michael A. Smith as Attorney-in-fact for Leo Lee. |
Recommendation
holdThe filing details a director's sale of shares under a pre-arranged 10b5-1 plan. While insider sales are often scrutinized, a 10b5-1 plan suggests the transaction was scheduled in advance and not necessarily based on new, material non-public information. Therefore, this specific transaction alone does not provide a strong basis for a 'buy' or 'sell' recommendation, warranting a 'hold' as other fundamental factors would be more influential.
Keywords
INSMED Inc., INSM, Leo Lee, Insider Sale, Form 4, Director Transaction, Stock Sale, Rule 10b5-1
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.